SCHEMBL16263780

SCHEMBL16263780

Cc1cccnc1[S+]([O-])c1cc(C(N)=O)c(NC(=O)C(C)(C)O)s1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CFTR P13569 4/20 0.45
▸ IKBKB O14920 3/20 0.36
▸ RAB9A P51151 4/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ NPC1 O15118 3/20 0.35
▸ MAPT P10636 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ AHR P35869 1/20 0.34
▸ MAP4K2 Q12851 1/20 0.33
▸ JAK2 O60674 3/20 0.33
▸ JAK3 P52333 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16263850 0.77 CFTR (0.53) CFTRIKBKBRAB9AALDH1A1NPC1
SCHEMBL19494373 0.75 CFTR (0.48) CFTRIKBKBJAK2KMT2A
SCHEMBL19494946 0.75 CFTR (0.51) CFTRIKBKBRAB9ASMN1; SMN2ALDH1A1
SCHEMBL16337048 0.75 CFTR (0.60) CFTRIKBKBRAB9ASMN1; SMN2ALDH1A1
SCHEMBL19494685 0.74 CFTR (0.49) CFTRIKBKBALDH1A1JAK2KMT2A
SCHEMBL19494765 0.72 CFTR (0.54) CFTRIKBKBRAB9AALDH1A1NPC1
SCHEMBL19494465 0.71 CFTR (0.43) CFTRIKBKBRAB9ANPC1JAK2
SCHEMBL16263805 0.70 CFTR (0.55) CFTRIKBKBRAB9AALDH1A1NPC1
SCHEMBL19494571 0.69 CFTR (0.46) CFTRIKBKBJAK2KMT2A
SCHEMBL19494317 0.69 CFTR (0.47) CFTRIKBKBRAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994463-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS GALAPAGOS NV (BE) 2017-10-25 — — EP disclosed
WO-2014180562-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS GALAPAGOS NV (BE) 2014-11-13 — — WO disclosed
Send feedback